leptin (Neurotez/GCA Therapeutics)

N/A

Report date: 2025/01/26 19:16:25

Base Information

Drug Nameleptin (Neurotez/GCA Therapeutics)
Drug Alias NameMemtin
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionBeta amyloid A4 protein inhibitorsMicrotubule-associated protein tau modulatorsLeptin receptor agonists
TargetsMicrotubule-associated protein tauBeta amyloid A4 proteinLeptin receptor
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNeurotez Inc
China Registration ClassN/A

Develop Information

Active CompaniesGCA Therapeutics LtdNeurotez Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A